Global Plasma-derived Medicinal Products Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030
Page: 154
Published Date: 02 Jan 2024
Category: Pharma & Healthcare
PDF Download
Get FREE Sample
Customize Request
-
Description
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Table of Contents
Table of Figures
Research Methodology
Companies Mentioned
Related Reports
Product Tags
Description
According to our (Global Info Research) latest study, the global Plasma-derived Medicinal Products market size was valued at USD 29140 million in 2023 and is forecast to a readjusted size of USD 47640 million by 2030 with a CAGR of 7.3% during review period.
Plasma-derived medicinal products (PDMPs) are industrially manufactured from human plasma by pharmaceutical companies. Plasma is the liquid part of blood and it can be collected through specific procedures called plasmapheresis or obtained by the separation from the other components through physical means (centrifugation). PDMPs play a key, and sometimes non-replaceable, role in the treatment of many acute and chronic clinical conditions.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The Global Info Research report includes an overview of the development of the Plasma-derived Medicinal Products industry chain, the market status of Emergency Care (Immunoglobulins, Coagulation Factor Concentrates), Epidemic Diseasae (Immunoglobulins, Coagulation Factor Concentrates), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Plasma-derived Medicinal Products.
Regionally, the report analyzes the Plasma-derived Medicinal Products markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Plasma-derived Medicinal Products market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Plasma-derived Medicinal Products market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Plasma-derived Medicinal Products industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the sales quantity (K Units), revenue generated, and market share of different by Type (e.g., Immunoglobulins, Coagulation Factor Concentrates).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Plasma-derived Medicinal Products market.
Regional Analysis: The report involves examining the Plasma-derived Medicinal Products market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Plasma-derived Medicinal Products market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Plasma-derived Medicinal Products:
Company Analysis: Report covers individual Plasma-derived Medicinal Products manufacturers, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Plasma-derived Medicinal Products This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Emergency Care, Epidemic Diseasae).
Technology Analysis: Report covers specific technologies relevant to Plasma-derived Medicinal Products. It assesses the current state, advancements, and potential future developments in Plasma-derived Medicinal Products areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Plasma-derived Medicinal Products market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Plasma-derived Medicinal Products market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Immunoglobulins
Coagulation Factor Concentrates
Other
Market segment by Application
Emergency Care
Epidemic Diseasae
Immune System Disorder
Antibody Deficiency
Coagulation Disorder
Others
Major players covered
Takeda
CSL
Grifols
Octapharma
Kedrion
LFB Group
Biotest
BPL
Shanghai RAAS
China Biologic Products
Hualan Biological Engineering Inc.
Beijing Tiantan Biological Products Corp
Pacific Shuanglin
Boya Bio-Pharmaceutical
Paisi Feike Biology Pharmacy Co., Ltd.
Xinjiang Deyuan Bioengineering
Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
Shenzhen Weiguang
Shanxi Kangbao
Nanyue Biopharming Corporation Ltd
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Plasma-derived Medicinal Products product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Plasma-derived Medicinal Products, with price, sales, revenue and global market share of Plasma-derived Medicinal Products from 2019 to 2024.
Chapter 3, the Plasma-derived Medicinal Products competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Plasma-derived Medicinal Products breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2019 to 2030.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2019 to 2030.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2023.and Plasma-derived Medicinal Products market forecast, by regions, type and application, with sales and revenue, from 2025 to 2030.
Chapter 12, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Plasma-derived Medicinal Products.
Chapter 14 and 15, to describe Plasma-derived Medicinal Products sales channel, distributors, customers, research findings and conclusion.
Table of Contents
1 Market Overview
1.1 Product Overview and Scope of Plasma-derived Medicinal Products
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Plasma-derived Medicinal Products Consumption Value by Type: 2019 Versus 2023 Versus 2030
1.3.2 Immunoglobulins
1.3.3 Coagulation Factor Concentrates
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Plasma-derived Medicinal Products Consumption Value by Application: 2019 Versus 2023 Versus 2030
1.4.2 Emergency Care
1.4.3 Epidemic Diseasae
1.4.4 Immune System Disorder
1.4.5 Antibody Deficiency
1.4.6 Coagulation Disorder
1.4.7 Others
1.5 Global Plasma-derived Medicinal Products Market Size & Forecast
1.5.1 Global Plasma-derived Medicinal Products Consumption Value (2019 & 2023 & 2030)
1.5.2 Global Plasma-derived Medicinal Products Sales Quantity (2019-2030)
1.5.3 Global Plasma-derived Medicinal Products Average Price (2019-2030)
2.1 Takeda
2.1.1 Takeda Details
2.1.2 Takeda Major Business
2.1.3 Takeda Plasma-derived Medicinal Products Product and Services
2.1.4 Takeda Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Takeda Recent Developments/Updates
2.2 CSL
2.2.1 CSL Details
2.2.2 CSL Major Business
2.2.3 CSL Plasma-derived Medicinal Products Product and Services
2.2.4 CSL Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 CSL Recent Developments/Updates
2.3 Grifols
2.3.1 Grifols Details
2.3.2 Grifols Major Business
2.3.3 Grifols Plasma-derived Medicinal Products Product and Services
2.3.4 Grifols Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Grifols Recent Developments/Updates
2.4 Octapharma
2.4.1 Octapharma Details
2.4.2 Octapharma Major Business
2.4.3 Octapharma Plasma-derived Medicinal Products Product and Services
2.4.4 Octapharma Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Octapharma Recent Developments/Updates
2.5 Kedrion
2.5.1 Kedrion Details
2.5.2 Kedrion Major Business
2.5.3 Kedrion Plasma-derived Medicinal Products Product and Services
2.5.4 Kedrion Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Kedrion Recent Developments/Updates
2.6 LFB Group
2.6.1 LFB Group Details
2.6.2 LFB Group Major Business
2.6.3 LFB Group Plasma-derived Medicinal Products Product and Services
2.6.4 LFB Group Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 LFB Group Recent Developments/Updates
2.7 Biotest
2.7.1 Biotest Details
2.7.2 Biotest Major Business
2.7.3 Biotest Plasma-derived Medicinal Products Product and Services
2.7.4 Biotest Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Biotest Recent Developments/Updates
2.8 BPL
2.8.1 BPL Details
2.8.2 BPL Major Business
2.8.3 BPL Plasma-derived Medicinal Products Product and Services
2.8.4 BPL Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 BPL Recent Developments/Updates
2.9 Shanghai RAAS
2.9.1 Shanghai RAAS Details
2.9.2 Shanghai RAAS Major Business
2.9.3 Shanghai RAAS Plasma-derived Medicinal Products Product and Services
2.9.4 Shanghai RAAS Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Shanghai RAAS Recent Developments/Updates
2.10 China Biologic Products
2.10.1 China Biologic Products Details
2.10.2 China Biologic Products Major Business
2.10.3 China Biologic Products Plasma-derived Medicinal Products Product and Services
2.10.4 China Biologic Products Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 China Biologic Products Recent Developments/Updates
2.11 Hualan Biological Engineering Inc.
2.11.1 Hualan Biological Engineering Inc. Details
2.11.2 Hualan Biological Engineering Inc. Major Business
2.11.3 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product and Services
2.11.4 Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Hualan Biological Engineering Inc. Recent Developments/Updates
2.12 Beijing Tiantan Biological Products Corp
2.12.1 Beijing Tiantan Biological Products Corp Details
2.12.2 Beijing Tiantan Biological Products Corp Major Business
2.12.3 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product and Services
2.12.4 Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Beijing Tiantan Biological Products Corp Recent Developments/Updates
2.13 Pacific Shuanglin
2.13.1 Pacific Shuanglin Details
2.13.2 Pacific Shuanglin Major Business
2.13.3 Pacific Shuanglin Plasma-derived Medicinal Products Product and Services
2.13.4 Pacific Shuanglin Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Pacific Shuanglin Recent Developments/Updates
2.14 Boya Bio-Pharmaceutical
2.14.1 Boya Bio-Pharmaceutical Details
2.14.2 Boya Bio-Pharmaceutical Major Business
2.14.3 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product and Services
2.14.4 Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Boya Bio-Pharmaceutical Recent Developments/Updates
2.15 Paisi Feike Biology Pharmacy Co., Ltd.
2.15.1 Paisi Feike Biology Pharmacy Co., Ltd. Details
2.15.2 Paisi Feike Biology Pharmacy Co., Ltd. Major Business
2.15.3 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product and Services
2.15.4 Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
2.16 Xinjiang Deyuan Bioengineering
2.16.1 Xinjiang Deyuan Bioengineering Details
2.16.2 Xinjiang Deyuan Bioengineering Major Business
2.16.3 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product and Services
2.16.4 Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Xinjiang Deyuan Bioengineering Recent Developments/Updates
2.17 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd.
2.17.1 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Details
2.17.2 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
2.17.3 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product and Services
2.17.4 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
2.18 Shenzhen Weiguang
2.18.1 Shenzhen Weiguang Details
2.18.2 Shenzhen Weiguang Major Business
2.18.3 Shenzhen Weiguang Plasma-derived Medicinal Products Product and Services
2.18.4 Shenzhen Weiguang Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Shenzhen Weiguang Recent Developments/Updates
2.19 Shanxi Kangbao
2.19.1 Shanxi Kangbao Details
2.19.2 Shanxi Kangbao Major Business
2.19.3 Shanxi Kangbao Plasma-derived Medicinal Products Product and Services
2.19.4 Shanxi Kangbao Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.19.5 Shanxi Kangbao Recent Developments/Updates
2.20 Nanyue Biopharming Corporation Ltd
2.20.1 Nanyue Biopharming Corporation Ltd Details
2.20.2 Nanyue Biopharming Corporation Ltd Major Business
2.20.3 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product and Services
2.20.4 Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2019-2024)
2.20.5 Nanyue Biopharming Corporation Ltd Recent Developments/Updates
3.1 Global Plasma-derived Medicinal Products Sales Quantity by Manufacturer (2019-2024)
3.2 Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2024)
3.3 Global Plasma-derived Medicinal Products Average Price by Manufacturer (2019-2024)
3.4 Market Share Analysis (2023)
3.4.1 Producer Shipments of Plasma-derived Medicinal Products by Manufacturer Revenue ($MM) and Market Share (%): 2023
3.4.2 Top 3 Plasma-derived Medicinal Products Manufacturer Market Share in 2023
3.4.2 Top 6 Plasma-derived Medicinal Products Manufacturer Market Share in 2023
3.5 Plasma-derived Medicinal Products Market: Overall Company Footprint Analysis
3.5.1 Plasma-derived Medicinal Products Market: Region Footprint
3.5.2 Plasma-derived Medicinal Products Market: Company Product Type Footprint
3.5.3 Plasma-derived Medicinal Products Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4.1 Global Plasma-derived Medicinal Products Market Size by Region
4.1.1 Global Plasma-derived Medicinal Products Sales Quantity by Region (2019-2030)
4.1.2 Global Plasma-derived Medicinal Products Consumption Value by Region (2019-2030)
4.1.3 Global Plasma-derived Medicinal Products Average Price by Region (2019-2030)
4.2 North America Plasma-derived Medicinal Products Consumption Value (2019-2030)
4.3 Europe Plasma-derived Medicinal Products Consumption Value (2019-2030)
4.4 Asia-Pacific Plasma-derived Medicinal Products Consumption Value (2019-2030)
4.5 South America Plasma-derived Medicinal Products Consumption Value (2019-2030)
4.6 Middle East and Africa Plasma-derived Medicinal Products Consumption Value (2019-2030)
5.1 Global Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
5.2 Global Plasma-derived Medicinal Products Consumption Value by Type (2019-2030)
5.3 Global Plasma-derived Medicinal Products Average Price by Type (2019-2030)
6.1 Global Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
6.2 Global Plasma-derived Medicinal Products Consumption Value by Application (2019-2030)
6.3 Global Plasma-derived Medicinal Products Average Price by Application (2019-2030)
7.1 North America Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
7.2 North America Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
7.3 North America Plasma-derived Medicinal Products Market Size by Country
7.3.1 North America Plasma-derived Medicinal Products Sales Quantity by Country (2019-2030)
7.3.2 North America Plasma-derived Medicinal Products Consumption Value by Country (2019-2030)
7.3.3 United States Market Size and Forecast (2019-2030)
7.3.4 Canada Market Size and Forecast (2019-2030)
7.3.5 Mexico Market Size and Forecast (2019-2030)
8.1 Europe Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
8.2 Europe Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
8.3 Europe Plasma-derived Medicinal Products Market Size by Country
8.3.1 Europe Plasma-derived Medicinal Products Sales Quantity by Country (2019-2030)
8.3.2 Europe Plasma-derived Medicinal Products Consumption Value by Country (2019-2030)
8.3.3 Germany Market Size and Forecast (2019-2030)
8.3.4 France Market Size and Forecast (2019-2030)
8.3.5 United Kingdom Market Size and Forecast (2019-2030)
8.3.6 Russia Market Size and Forecast (2019-2030)
8.3.7 Italy Market Size and Forecast (2019-2030)
9.1 Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
9.2 Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
9.3 Asia-Pacific Plasma-derived Medicinal Products Market Size by Region
9.3.1 Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Region (2019-2030)
9.3.2 Asia-Pacific Plasma-derived Medicinal Products Consumption Value by Region (2019-2030)
9.3.3 China Market Size and Forecast (2019-2030)
9.3.4 Japan Market Size and Forecast (2019-2030)
9.3.5 Korea Market Size and Forecast (2019-2030)
9.3.6 India Market Size and Forecast (2019-2030)
9.3.7 Southeast Asia Market Size and Forecast (2019-2030)
9.3.8 Australia Market Size and Forecast (2019-2030)
10.1 South America Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
10.2 South America Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
10.3 South America Plasma-derived Medicinal Products Market Size by Country
10.3.1 South America Plasma-derived Medicinal Products Sales Quantity by Country (2019-2030)
10.3.2 South America Plasma-derived Medicinal Products Consumption Value by Country (2019-2030)
10.3.3 Brazil Market Size and Forecast (2019-2030)
10.3.4 Argentina Market Size and Forecast (2019-2030)
11.1 Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Type (2019-2030)
11.2 Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Application (2019-2030)
11.3 Middle East & Africa Plasma-derived Medicinal Products Market Size by Country
11.3.1 Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Country (2019-2030)
11.3.2 Middle East & Africa Plasma-derived Medicinal Products Consumption Value by Country (2019-2030)
11.3.3 Turkey Market Size and Forecast (2019-2030)
11.3.4 Egypt Market Size and Forecast (2019-2030)
11.3.5 Saudi Arabia Market Size and Forecast (2019-2030)
11.3.6 South Africa Market Size and Forecast (2019-2030)
12.1 Plasma-derived Medicinal Products Market Drivers
12.2 Plasma-derived Medicinal Products Market Restraints
12.3 Plasma-derived Medicinal Products Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
13.1 Raw Material of Plasma-derived Medicinal Products and Key Manufacturers
13.2 Manufacturing Costs Percentage of Plasma-derived Medicinal Products
13.3 Plasma-derived Medicinal Products Production Process
13.4 Plasma-derived Medicinal Products Industrial Chain
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Plasma-derived Medicinal Products Typical Distributors
14.3 Plasma-derived Medicinal Products Typical Customers
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer
Table of Figures
List of Tables
Table 1. Global Plasma-derived Medicinal Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Plasma-derived Medicinal Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Takeda Basic Information, Manufacturing Base and Competitors
Table 4. Takeda Major Business
Table 5. Takeda Plasma-derived Medicinal Products Product and Services
Table 6. Takeda Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 7. Takeda Recent Developments/Updates
Table 8. CSL Basic Information, Manufacturing Base and Competitors
Table 9. CSL Major Business
Table 10. CSL Plasma-derived Medicinal Products Product and Services
Table 11. CSL Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 12. CSL Recent Developments/Updates
Table 13. Grifols Basic Information, Manufacturing Base and Competitors
Table 14. Grifols Major Business
Table 15. Grifols Plasma-derived Medicinal Products Product and Services
Table 16. Grifols Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 17. Grifols Recent Developments/Updates
Table 18. Octapharma Basic Information, Manufacturing Base and Competitors
Table 19. Octapharma Major Business
Table 20. Octapharma Plasma-derived Medicinal Products Product and Services
Table 21. Octapharma Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 22. Octapharma Recent Developments/Updates
Table 23. Kedrion Basic Information, Manufacturing Base and Competitors
Table 24. Kedrion Major Business
Table 25. Kedrion Plasma-derived Medicinal Products Product and Services
Table 26. Kedrion Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 27. Kedrion Recent Developments/Updates
Table 28. LFB Group Basic Information, Manufacturing Base and Competitors
Table 29. LFB Group Major Business
Table 30. LFB Group Plasma-derived Medicinal Products Product and Services
Table 31. LFB Group Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 32. LFB Group Recent Developments/Updates
Table 33. Biotest Basic Information, Manufacturing Base and Competitors
Table 34. Biotest Major Business
Table 35. Biotest Plasma-derived Medicinal Products Product and Services
Table 36. Biotest Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 37. Biotest Recent Developments/Updates
Table 38. BPL Basic Information, Manufacturing Base and Competitors
Table 39. BPL Major Business
Table 40. BPL Plasma-derived Medicinal Products Product and Services
Table 41. BPL Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 42. BPL Recent Developments/Updates
Table 43. Shanghai RAAS Basic Information, Manufacturing Base and Competitors
Table 44. Shanghai RAAS Major Business
Table 45. Shanghai RAAS Plasma-derived Medicinal Products Product and Services
Table 46. Shanghai RAAS Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 47. Shanghai RAAS Recent Developments/Updates
Table 48. China Biologic Products Basic Information, Manufacturing Base and Competitors
Table 49. China Biologic Products Major Business
Table 50. China Biologic Products Plasma-derived Medicinal Products Product and Services
Table 51. China Biologic Products Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 52. China Biologic Products Recent Developments/Updates
Table 53. Hualan Biological Engineering Inc. Basic Information, Manufacturing Base and Competitors
Table 54. Hualan Biological Engineering Inc. Major Business
Table 55. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Product and Services
Table 56. Hualan Biological Engineering Inc. Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 57. Hualan Biological Engineering Inc. Recent Developments/Updates
Table 58. Beijing Tiantan Biological Products Corp Basic Information, Manufacturing Base and Competitors
Table 59. Beijing Tiantan Biological Products Corp Major Business
Table 60. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Product and Services
Table 61. Beijing Tiantan Biological Products Corp Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 62. Beijing Tiantan Biological Products Corp Recent Developments/Updates
Table 63. Pacific Shuanglin Basic Information, Manufacturing Base and Competitors
Table 64. Pacific Shuanglin Major Business
Table 65. Pacific Shuanglin Plasma-derived Medicinal Products Product and Services
Table 66. Pacific Shuanglin Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 67. Pacific Shuanglin Recent Developments/Updates
Table 68. Boya Bio-Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 69. Boya Bio-Pharmaceutical Major Business
Table 70. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Product and Services
Table 71. Boya Bio-Pharmaceutical Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 72. Boya Bio-Pharmaceutical Recent Developments/Updates
Table 73. Paisi Feike Biology Pharmacy Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 74. Paisi Feike Biology Pharmacy Co., Ltd. Major Business
Table 75. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Product and Services
Table 76. Paisi Feike Biology Pharmacy Co., Ltd. Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 77. Paisi Feike Biology Pharmacy Co., Ltd. Recent Developments/Updates
Table 78. Xinjiang Deyuan Bioengineering Basic Information, Manufacturing Base and Competitors
Table 79. Xinjiang Deyuan Bioengineering Major Business
Table 80. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Product and Services
Table 81. Xinjiang Deyuan Bioengineering Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 82. Xinjiang Deyuan Bioengineering Recent Developments/Updates
Table 83. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Basic Information, Manufacturing Base and Competitors
Table 84. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Major Business
Table 85. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Product and Services
Table 86. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 87. Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Recent Developments/Updates
Table 88. Shenzhen Weiguang Basic Information, Manufacturing Base and Competitors
Table 89. Shenzhen Weiguang Major Business
Table 90. Shenzhen Weiguang Plasma-derived Medicinal Products Product and Services
Table 91. Shenzhen Weiguang Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 92. Shenzhen Weiguang Recent Developments/Updates
Table 93. Shanxi Kangbao Basic Information, Manufacturing Base and Competitors
Table 94. Shanxi Kangbao Major Business
Table 95. Shanxi Kangbao Plasma-derived Medicinal Products Product and Services
Table 96. Shanxi Kangbao Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 97. Shanxi Kangbao Recent Developments/Updates
Table 98. Nanyue Biopharming Corporation Ltd Basic Information, Manufacturing Base and Competitors
Table 99. Nanyue Biopharming Corporation Ltd Major Business
Table 100. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Product and Services
Table 101. Nanyue Biopharming Corporation Ltd Plasma-derived Medicinal Products Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 102. Nanyue Biopharming Corporation Ltd Recent Developments/Updates
Table 103. Global Plasma-derived Medicinal Products Sales Quantity by Manufacturer (2019-2024) & (K Units)
Table 104. Global Plasma-derived Medicinal Products Revenue by Manufacturer (2019-2024) & (USD Million)
Table 105. Global Plasma-derived Medicinal Products Average Price by Manufacturer (2019-2024) & (US$/Unit)
Table 106. Market Position of Manufacturers in Plasma-derived Medicinal Products, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2023
Table 107. Head Office and Plasma-derived Medicinal Products Production Site of Key Manufacturer
Table 108. Plasma-derived Medicinal Products Market: Company Product Type Footprint
Table 109. Plasma-derived Medicinal Products Market: Company Product Application Footprint
Table 110. Plasma-derived Medicinal Products New Market Entrants and Barriers to Market Entry
Table 111. Plasma-derived Medicinal Products Mergers, Acquisition, Agreements, and Collaborations
Table 112. Global Plasma-derived Medicinal Products Sales Quantity by Region (2019-2024) & (K Units)
Table 113. Global Plasma-derived Medicinal Products Sales Quantity by Region (2025-2030) & (K Units)
Table 114. Global Plasma-derived Medicinal Products Consumption Value by Region (2019-2024) & (USD Million)
Table 115. Global Plasma-derived Medicinal Products Consumption Value by Region (2025-2030) & (USD Million)
Table 116. Global Plasma-derived Medicinal Products Average Price by Region (2019-2024) & (US$/Unit)
Table 117. Global Plasma-derived Medicinal Products Average Price by Region (2025-2030) & (US$/Unit)
Table 118. Global Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 119. Global Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 120. Global Plasma-derived Medicinal Products Consumption Value by Type (2019-2024) & (USD Million)
Table 121. Global Plasma-derived Medicinal Products Consumption Value by Type (2025-2030) & (USD Million)
Table 122. Global Plasma-derived Medicinal Products Average Price by Type (2019-2024) & (US$/Unit)
Table 123. Global Plasma-derived Medicinal Products Average Price by Type (2025-2030) & (US$/Unit)
Table 124. Global Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 125. Global Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 126. Global Plasma-derived Medicinal Products Consumption Value by Application (2019-2024) & (USD Million)
Table 127. Global Plasma-derived Medicinal Products Consumption Value by Application (2025-2030) & (USD Million)
Table 128. Global Plasma-derived Medicinal Products Average Price by Application (2019-2024) & (US$/Unit)
Table 129. Global Plasma-derived Medicinal Products Average Price by Application (2025-2030) & (US$/Unit)
Table 130. North America Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 131. North America Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 132. North America Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 133. North America Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 134. North America Plasma-derived Medicinal Products Sales Quantity by Country (2019-2024) & (K Units)
Table 135. North America Plasma-derived Medicinal Products Sales Quantity by Country (2025-2030) & (K Units)
Table 136. North America Plasma-derived Medicinal Products Consumption Value by Country (2019-2024) & (USD Million)
Table 137. North America Plasma-derived Medicinal Products Consumption Value by Country (2025-2030) & (USD Million)
Table 138. Europe Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 139. Europe Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 140. Europe Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 141. Europe Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 142. Europe Plasma-derived Medicinal Products Sales Quantity by Country (2019-2024) & (K Units)
Table 143. Europe Plasma-derived Medicinal Products Sales Quantity by Country (2025-2030) & (K Units)
Table 144. Europe Plasma-derived Medicinal Products Consumption Value by Country (2019-2024) & (USD Million)
Table 145. Europe Plasma-derived Medicinal Products Consumption Value by Country (2025-2030) & (USD Million)
Table 146. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 147. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 148. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 149. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 150. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Region (2019-2024) & (K Units)
Table 151. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity by Region (2025-2030) & (K Units)
Table 152. Asia-Pacific Plasma-derived Medicinal Products Consumption Value by Region (2019-2024) & (USD Million)
Table 153. Asia-Pacific Plasma-derived Medicinal Products Consumption Value by Region (2025-2030) & (USD Million)
Table 154. South America Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 155. South America Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 156. South America Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 157. South America Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 158. South America Plasma-derived Medicinal Products Sales Quantity by Country (2019-2024) & (K Units)
Table 159. South America Plasma-derived Medicinal Products Sales Quantity by Country (2025-2030) & (K Units)
Table 160. South America Plasma-derived Medicinal Products Consumption Value by Country (2019-2024) & (USD Million)
Table 161. South America Plasma-derived Medicinal Products Consumption Value by Country (2025-2030) & (USD Million)
Table 162. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Type (2019-2024) & (K Units)
Table 163. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Type (2025-2030) & (K Units)
Table 164. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Application (2019-2024) & (K Units)
Table 165. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Application (2025-2030) & (K Units)
Table 166. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Region (2019-2024) & (K Units)
Table 167. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity by Region (2025-2030) & (K Units)
Table 168. Middle East & Africa Plasma-derived Medicinal Products Consumption Value by Region (2019-2024) & (USD Million)
Table 169. Middle East & Africa Plasma-derived Medicinal Products Consumption Value by Region (2025-2030) & (USD Million)
Table 170. Plasma-derived Medicinal Products Raw Material
Table 171. Key Manufacturers of Plasma-derived Medicinal Products Raw Materials
Table 172. Plasma-derived Medicinal Products Typical Distributors
Table 173. Plasma-derived Medicinal Products Typical Customers
List of Figures
Figure 1. Plasma-derived Medicinal Products Picture
Figure 2. Global Plasma-derived Medicinal Products Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Plasma-derived Medicinal Products Consumption Value Market Share by Type in 2023
Figure 4. Immunoglobulins Examples
Figure 5. Coagulation Factor Concentrates Examples
Figure 6. Other Examples
Figure 7. Global Plasma-derived Medicinal Products Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Figure 8. Global Plasma-derived Medicinal Products Consumption Value Market Share by Application in 2023
Figure 9. Emergency Care Examples
Figure 10. Epidemic Diseasae Examples
Figure 11. Immune System Disorder Examples
Figure 12. Antibody Deficiency Examples
Figure 13. Coagulation Disorder Examples
Figure 14. Others Examples
Figure 15. Global Plasma-derived Medicinal Products Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 16. Global Plasma-derived Medicinal Products Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 17. Global Plasma-derived Medicinal Products Sales Quantity (2019-2030) & (K Units)
Figure 18. Global Plasma-derived Medicinal Products Average Price (2019-2030) & (US$/Unit)
Figure 19. Global Plasma-derived Medicinal Products Sales Quantity Market Share by Manufacturer in 2023
Figure 20. Global Plasma-derived Medicinal Products Consumption Value Market Share by Manufacturer in 2023
Figure 21. Producer Shipments of Plasma-derived Medicinal Products by Manufacturer Sales Quantity ($MM) and Market Share (%): 2023
Figure 22. Top 3 Plasma-derived Medicinal Products Manufacturer (Consumption Value) Market Share in 2023
Figure 23. Top 6 Plasma-derived Medicinal Products Manufacturer (Consumption Value) Market Share in 2023
Figure 24. Global Plasma-derived Medicinal Products Sales Quantity Market Share by Region (2019-2030)
Figure 25. Global Plasma-derived Medicinal Products Consumption Value Market Share by Region (2019-2030)
Figure 26. North America Plasma-derived Medicinal Products Consumption Value (2019-2030) & (USD Million)
Figure 27. Europe Plasma-derived Medicinal Products Consumption Value (2019-2030) & (USD Million)
Figure 28. Asia-Pacific Plasma-derived Medicinal Products Consumption Value (2019-2030) & (USD Million)
Figure 29. South America Plasma-derived Medicinal Products Consumption Value (2019-2030) & (USD Million)
Figure 30. Middle East & Africa Plasma-derived Medicinal Products Consumption Value (2019-2030) & (USD Million)
Figure 31. Global Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 32. Global Plasma-derived Medicinal Products Consumption Value Market Share by Type (2019-2030)
Figure 33. Global Plasma-derived Medicinal Products Average Price by Type (2019-2030) & (US$/Unit)
Figure 34. Global Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 35. Global Plasma-derived Medicinal Products Consumption Value Market Share by Application (2019-2030)
Figure 36. Global Plasma-derived Medicinal Products Average Price by Application (2019-2030) & (US$/Unit)
Figure 37. North America Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 38. North America Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 39. North America Plasma-derived Medicinal Products Sales Quantity Market Share by Country (2019-2030)
Figure 40. North America Plasma-derived Medicinal Products Consumption Value Market Share by Country (2019-2030)
Figure 41. United States Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 42. Canada Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 43. Mexico Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 44. Europe Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 45. Europe Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 46. Europe Plasma-derived Medicinal Products Sales Quantity Market Share by Country (2019-2030)
Figure 47. Europe Plasma-derived Medicinal Products Consumption Value Market Share by Country (2019-2030)
Figure 48. Germany Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 49. France Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 50. United Kingdom Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 51. Russia Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 52. Italy Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 53. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 54. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 55. Asia-Pacific Plasma-derived Medicinal Products Sales Quantity Market Share by Region (2019-2030)
Figure 56. Asia-Pacific Plasma-derived Medicinal Products Consumption Value Market Share by Region (2019-2030)
Figure 57. China Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 58. Japan Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 59. Korea Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 60. India Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 61. Southeast Asia Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 62. Australia Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 63. South America Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 64. South America Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 65. South America Plasma-derived Medicinal Products Sales Quantity Market Share by Country (2019-2030)
Figure 66. South America Plasma-derived Medicinal Products Consumption Value Market Share by Country (2019-2030)
Figure 67. Brazil Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 68. Argentina Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 69. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity Market Share by Type (2019-2030)
Figure 70. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity Market Share by Application (2019-2030)
Figure 71. Middle East & Africa Plasma-derived Medicinal Products Sales Quantity Market Share by Region (2019-2030)
Figure 72. Middle East & Africa Plasma-derived Medicinal Products Consumption Value Market Share by Region (2019-2030)
Figure 73. Turkey Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 74. Egypt Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 75. Saudi Arabia Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 76. South Africa Plasma-derived Medicinal Products Consumption Value and Growth Rate (2019-2030) & (USD Million)
Figure 77. Plasma-derived Medicinal Products Market Drivers
Figure 78. Plasma-derived Medicinal Products Market Restraints
Figure 79. Plasma-derived Medicinal Products Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Manufacturing Cost Structure Analysis of Plasma-derived Medicinal Products in 2023
Figure 82. Manufacturing Process Analysis of Plasma-derived Medicinal Products
Figure 83. Plasma-derived Medicinal Products Industrial Chain
Figure 84. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 85. Direct Channel Pros & Cons
Figure 86. Indirect Channel Pros & Cons
Figure 87. Methodology
Figure 88. Research Process and Data Source
Research Methodology
Client Requirements
Review and analyze client requirements
Discussion of all the project requirements and queries
Flexibility Check
Project Feasibility Analysis
Finalizing tentative research programme
Structuring project proposal with scope, timeline, and costs
Analyzing Market Dynamics
Determination of key drivers, restraints, challenge, and opportunity
Identifies market needs and trends
Market Size Estimation & Forecast
Estimation of historical data based on secondary and primary data
Anticipating market recast by assigning weightage to market forces (drivers, restraints, opportunities)
Freezing historical and forecast market size estimations based on evolution, trends, outlook, and strategies
Consideration of geography, region-specific product/service demand for region segments
Consideration of product utilization rates, product demand outlook for segments by application or end-user.
Data Source
Secondary Source
Data collections from annual reports, presentations,associations, journals, analyst reports,
paid database, press releases, blogs, newsletters,and GIR repositories.
Primary Source
Research discussion with manufacturers, distributors, suppliers, end user, industry experts
to verify insights.
Validation
and
triangulation of
secondary and primary source.
Collection of data
Cumulating and collating the essential qualitative and quantitative data
Generation of report in client requested format by research analysts
Reviews by expert analysts
Final quality check
Clarifying queries
Receiving feedback
Ensuring satisfaction
01 Identification of data
This step involves identification of several primary and secondary data research sources, including Global Info Research's internal data sources. The primary sources consist of in-depth discussions and interviews with policy makers, industry experts, and data evaluators, whereas secondary sources include a thorough study of market journals, press releases, annual reports, and government and non-government agencies websites.
-
02 Evaluation of Market Dynamic
This phase includes a detailed evaluation of several factors that are likely to affect the market dynamics. It involves a comprehensive assessment of major market pain points, drivers, and trends. It also comprises a detailed study of research plans and methodology.
-
03 Collection of Data
This process consists of gathering data, accessing proprietary databases, and reaching out to key industry participants that operate in the market across the value chain. It also involves studying several patterns in the historical data and comparing it with the current scenario.
-
04 Collaboration of Data
This stage involves the validation of data and arrival at actual statistics, and evolution of the market over the years. It entails the study and analyzes various segments and verticals of the market. An impact analysis is also performed to observe which factors will affect the market in the next few years.
05 Verification and Analysis
This is the final stage, which involves both quantity and quality checks. Although the process of data verification is an integral part of the research process, all data points and statistics and figures are re-checked to uphold their authenticity and validity.
Companies Mentioned
Takeda CSL Grifols Octapharma Kedrion LFB Group Biotest BPL Shanghai RAAS China Biologic Products Hualan Biological Engineering Inc. Beijing Tiantan Biological Products Corp Pacific Shuanglin Boya Bio-Pharmaceutical Paisi Feike Biology Pharmacy Co., Ltd. Xinjiang Deyuan Bioengineering Sichuan Yuanda Shuyang Pharmaceutical Co., Ltd. Shenzhen Weiguang Shanxi Kangbao Nanyue Biopharming Corporation Ltd
Related Reports
26 Aug 2023
Pharma & Healthcare
Purchase Options
Add To Cart
Buy Now
Popular Product Keywords
- We Provide Professional, Accurate Market Analysis to Help You Stay Ahead of Your Competition.Speak to our analyst >>
Our Clients
What We Can Provide?
With better results and higher quality products,Our professional reports can achieve four things:
Insight into the industry market information
Analyze market development needs
Prospects for future development
Develop industry investment strategy
- Digging deeper into global industry information and providing market strategies.Contact Us >>
